Action Altimmune - ALT

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

7,55

Prix Achat

7,54

Prix Vente

7,59

Volume échangé

1 339 650

7,50 Fourchette du Jour 7,80

5,275 Plage de 52 semaines 14,84

Cap du marché

536,991M

Clôture Veille

7,76

Ouverture

7,76

Dernière Transaction

379

7.55

(formt)

Dernière heure de transaction

Volume financier

US$ 10 155 755

VWAP

7,5809

Volume moyen (3 m)

3 125 548

Actions en circulation

71 124 625

Rendement du Dividende

Ratio Cours sur Bénéfices

-6,07

Bénéfice par action (BPA)

-1,24

Chiffre d'affairess

426k

Bénéfice net

-88,45M

Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the tre... Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH (non-alcoholic steatohepatitis). In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B virus (HBV). Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.altimmune.com

Siège social

Wilmington, Delaware, USA

Fondé

Altimmune Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ALT. Le dernier cours de clôture d'Altimmune était de US$7,76. Au cours de la dernière année, les actions de Altimmune ont été négociées dans une fourchette de prix de US$ 5,275 à US$ 14,84.

Altimmune compte actuellement 71 124 625 actions en circulation. La capitalisation boursière d'Altimmune est de US$551,93 million. Altimmune a un ratio cours/bénéfice (ratio PE) de -6.07.

Altimmune Added to Nasdaq Biotechnology Index

GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will be added to the Nasdaq Biotechnology...

Form 8-K - Current report

Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders

GAITHERSBURG, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at...

Altimmune to Participate at Two Upcoming Investor Conferences

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will...

Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024

Weekly subcutaneous doses of pemvidutide resulted in robust reductions in cardio-inflammatory, hepato-inflammatory and atherosclerotic lipids Findings support the potential benefit of pemvidutide...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-1.3	-14.6892655367	8.85	8.882	7.55	3634237	8.09369868	CS
4	-1.13	-13.0184331797	8.68	10.88	7.55	3452428	8.85425922	CS
12	1.42	23.1647634584	6.13	11.16	5.86	3125548	8.16275105	CS
26	0.1	1.34228187919	7.45	11.16	5.275	3086315	7.47828756	CS
52	-1.99	-20.8595387841	9.54	14.84	5.275	3963798	8.82563437	CS
156	-1.59	-17.3960612691	9.14	23.49	2.09	2924950	8.12113951	CS
260	5.77	324.157303371	1.78	35.1	1.6	2518776	9.70597279	CS

ALT - Frequently Asked Questions (FAQ)

What is the current Altimmune share price?

The current share price of Altimmune is US$ 7,55

How many Altimmune shares are in issue?

Altimmune has 71 124 625 shares in issue

What is the market cap of Altimmune?

The market capitalisation of Altimmune is USD 551,93M

What is the 1 year trading range for Altimmune share price?

Altimmune has traded in the range of US$ 5,275 to US$ 14,84 during the past year

What is the PE ratio of Altimmune?

The price to earnings ratio of Altimmune is -6,07

What is the cash to sales ratio of Altimmune?

The cash to sales ratio of Altimmune is 1,26k

What is the reporting currency for Altimmune?

Altimmune reports financial results in USD

What is the latest annual turnover for Altimmune?

The latest annual turnover of Altimmune is USD 426k

What is the latest annual profit for Altimmune?

The latest annual profit of Altimmune is USD -88,45M

What is the registered address of Altimmune?

The registered address for Altimmune is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Altimmune website address?

The website address for Altimmune is www.altimmune.com

Which industry sector does Altimmune operate in?

Altimmune operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
BAOSBaosheng Media Group Holdings Ltd	US$ 7,10 (310,40%)	58,74M
HOURHour Loop Inc	US$ 4,40 (207,69%)	97,42M
GTIGraphjet Technology	US$ 0,61 (168,72%)	265,48M
CREVCarbon Revolution Public Ltd	US$ 9,16 (135,48%)	26,95M
AVGRAvinger Inc	US$ 1,45 (125,72%)	107,53M
SLGLSol Gel Technologies Ltd	US$ 0,9798 (-40,62%)	3,07M
DRCTDirect Digital Holdings Inc	US$ 3,71 (-32,55%)	23,82M
CHEKCheck Cap Ltd	US$ 1,55 (-31,11%)	3,49M
SYTASiyata Mobile Inc	US$ 0,5178 (-30,83%)	2,63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF	US$ 15,47 (-30,38%)	147,98k
SVMHSRIVARU Holding Ltd	US$ 0,0338 (20,71%)	280,27M
GTIGraphjet Technology	US$ 0,61 (168,72%)	265,48M
LITMSnow Lake Resources Ltd	US$ 0,5849 (52,84%)	181,22M
LCIDLucid Group Inc	US$ 3,20 (3,23%)	108,75M
RGTIRigetti Computing Inc	US$ 11,35 (3,56%)	108,38M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Altimmune Inc (ALT)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Altimmune Inc

ALT Dernières nouvelles

Altimmune Added to Nasdaq Biotechnology Index

Form 8-K - Current report

Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders

Altimmune to Participate at Two Upcoming Investor Conferences

Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Altimmune Announces Third Quarter 2024 Financial Results and Provides a Business Update

Form 8-K - Current report

Altimmune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Altimmune Added to Nasdaq Biotechnology Index

Form 8-K - Current report

Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders

Altimmune to Participate at Two Upcoming Investor Conferences

Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Altimmune Announces Third Quarter 2024 Financial Results and Provides a Business Update

Form 8-K - Current report

ALT - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Altimmune Inc (ALT) Cours

Altimmune Inc (ALT)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Altimmune Inc

ALT Dernières nouvelles

ALT - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application